Consolidated statement of income
Download(XLS, 46 KB)| € in millions | Note | 2022 | 2021 |
|---|---|---|---|
| Revenue | 4 | 40,840 | 37,520 |
| Costs of revenue | -30,115 | -27,209 | |
| Gross profit | 10,725 | 10,311 | |
| Selling expenses | -1,220 | -1,059 | |
| General and administrative expenses | 8 | -5,524 | -4,394 |
| Other operating income | 9 | 666 | 381 |
| Other operating expenses | 9 | -459 | -276 |
| Research and development expenses | 7 | -867 | -805 |
| Operating income (EBITEBIT (Earnings before Interest and Taxes)EBIT does include depreciation and write-ups on property, plant and equipment. EBIT is calculated by subtracting costs of revenue, selling, general and administrative expenses, and research and development expenses from revenue.) | 3,321 | 4,158 | |
| Interest income | 10 | 187 | 124 |
| Interest expenses | 10 | -694 | -630 |
| Income before income taxes | 2,814 | 3,652 | |
| Income taxes | 11 | -697 | -833 |
| Net income | 2,117 | 2,819 | |
| Noncontrolling interests | 12 | 745 | 1,001 |
| Net income attributable to shareholders of Fresenius SE & Co. KGaA | 1,372 | 1,818 | |
| Earnings per share in € | 14 | 2.44 | 3.26 |
| Fully diluted earnings per share in € | 14 | 2.44 | 3.26 |
| The following notes are an integral part of the consolidated financial statements. | |||